Crewe Advisors’s Opko Health OPK Stock Holding History

Crewe Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	1	–	–	﹤0.01%	1134
2026 Q1	$2	Hold	1	–	–	﹤0.01%	1036
2025 Q4	$2	Hold	1	–	–	﹤0.01%	1098
2025 Q3	$2	Hold	1	–	–	﹤0.01%	964
2025 Q2	$2	Buy	+1	New	+$1	﹤0.01%	747

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Crewe Advisors's OPK Position: Q2 2026 in Review

Crewe Advisors held its Opko Health (OPK) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Crewe Advisors first reported a position in OPK in Q2 2025 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

Crewe Advisors held 1 share of Opko Health worth $2 as of Q2 2026.
Crewe Advisors left its Opko Health share count unchanged in Q2 2026.
Opko Health made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #1134 holding.
Crewe Advisors first reported a position in Opko Health in Q2 2025 and has held it in 5 quarters since.
223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.